Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause severe placental lesions leading rapidly to intrauterine fetal death (IUFD). From August 2020 to September 2021, in the pathology department of Toulouse Oncopole, we analyzed 50 placentas from COVID-19–positive unvaccin...
Gespeichert in:
Veröffentlicht in: | Human pathology 2022-03, Vol.121, p.46-55 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 55 |
---|---|
container_issue | |
container_start_page | 46 |
container_title | Human pathology |
container_volume | 121 |
creator | Dubucs, Charlotte Groussolles, Marion Ousselin, Jessie Sartor, Agnès Van Acker, Nathalie Vayssière, Christophe Pasquier, Christophe Reyre, Joëlle Batlle, Laïa Favarel clinical research associate, Stèphanie Duchanois midwife, Delphine Jauffret clinical research associate, Valèrie Courtade-Saïdi, Monique Aziza, Jacqueline |
description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause severe placental lesions leading rapidly to intrauterine fetal death (IUFD). From August 2020 to September 2021, in the pathology department of Toulouse Oncopole, we analyzed 50 placentas from COVID-19–positive unvaccinated mothers.
The purpose of our study is to describe the clinicopathological characteristics of these placental damages and to understand the pathophysiology.
Ten of them (20%) showed placental lesions with positive immunohistochemistry for SARS-CoV-2 in villous trophoblasts. In five cases (10%), we observed massive placental damage associating trophoblastic necrosis, fibrinous deposits, intervillositis, as well as extensive hemorrhagic changes due to SARS-CoV-2 infection probably responsible of IUFD by functional placental insufficiency. In five other cases, we found similar placental lesions but with a focal distribution that did not lead to IUFD but live birth.
These lesions are independent of maternal clinical severity of COVID-19 infection because they occur despite mild maternal symptoms and are therefore difficult to predict. In our cases, they occurred 1–3 weeks after positive SARS-CoV-2 maternal real-time polymerase chain reaction testing and were observed in the 2nd and 3rd trimesters of pregnancies. When these lesions are focal, they do not lead to IUFD and can be involved in intrauterine growth restriction.
Our findings, together with recent observations, suggest that future pregnancy guidance should include stricter pandemic precautions such as screening for a wider array of COVID-19 symptoms, enhanced ultrasound monitoring, as well as newborn medical surveillance.
•Maternal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can generate severe placental lesions.•Some COVID-19–positive unvaccinated mothers show trophoblastic necrosis with positive anti-SARS-CoV-2 immunohistochemitrsy.•SARS-CoV-2 placental lesions can be involved in intrauterine fetal death (10% of cases) when placental damage is massive.•Intrauterine fetal death occurred 1–3 weeks after maternal infection in 2nd and 3rd trimesters of pregnancies.•Severe SARS-CoV-2 placenta lesions occur despite mild maternal COVID-19 symptoms. |
doi_str_mv | 10.1016/j.humpath.2021.12.012 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8730375</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0046817721002203</els_id><sourcerecordid>2638967296</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-3c8d70b67d1ede984c795968f53c37a6377ca021602a59efc126df44ab056a803</originalsourceid><addsrcrecordid>eNqFkV2LEzEUhoMobnf1JygD3rgXM-Zj8nWjlKKuUBCsehvS5IxNmU5qMlPw35uhddG98Spw8pz3nPe8CL0guCGYiDf7ZjcdjnbcNRRT0hDaYEIfoQXhjNaKafoYLTBuRa2IlFfoOuc9xoTwlj9FV6zVmgvZLpDfwAkSVMfeOhhG21c95BCHXPkJqjFWBztCGkp9s_yyqVfxe02rMHTgxkJVNufoQkH8zIZhTHYqfBig6mBW81BWfIaedLbP8Pzy3qBvH95_Xd3V688fP62W69pxqseaOeUl3grpCXjQqnVScy1Ux5lj0gompbPFrMDUcg2dI1T4rm3tFnNhFWY36O1Z9zhtD-BnQ8n25pjCwaZfJtpg_v0Zws78iCejJMNM8iJwexbYPWi7W67NXMMt51wpdSKFfX0ZluLPCfJoDiE76Hs7QJyyoYIoyrDgbUFfPUD3cZqPOlNMaSGpFoXiZ8qlmHOC7n4Dgs2cudmbS-ZmztwQakrmpe_l367vu_6EXIB3ZwDK7U8BkskuwODAh1RyND6G_4z4DU5Rv-c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2638967296</pqid></control><display><type>article</type><title>Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Dubucs, Charlotte ; Groussolles, Marion ; Ousselin, Jessie ; Sartor, Agnès ; Van Acker, Nathalie ; Vayssière, Christophe ; Pasquier, Christophe ; Reyre, Joëlle ; Batlle, Laïa ; Favarel clinical research associate, Stèphanie ; Duchanois midwife, Delphine ; Jauffret clinical research associate, Valèrie ; Courtade-Saïdi, Monique ; Aziza, Jacqueline</creator><creatorcontrib>Dubucs, Charlotte ; Groussolles, Marion ; Ousselin, Jessie ; Sartor, Agnès ; Van Acker, Nathalie ; Vayssière, Christophe ; Pasquier, Christophe ; Reyre, Joëlle ; Batlle, Laïa ; Favarel clinical research associate, Stèphanie ; Duchanois midwife, Delphine ; Jauffret clinical research associate, Valèrie ; Courtade-Saïdi, Monique ; Aziza, Jacqueline</creatorcontrib><description>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause severe placental lesions leading rapidly to intrauterine fetal death (IUFD). From August 2020 to September 2021, in the pathology department of Toulouse Oncopole, we analyzed 50 placentas from COVID-19–positive unvaccinated mothers.
The purpose of our study is to describe the clinicopathological characteristics of these placental damages and to understand the pathophysiology.
Ten of them (20%) showed placental lesions with positive immunohistochemistry for SARS-CoV-2 in villous trophoblasts. In five cases (10%), we observed massive placental damage associating trophoblastic necrosis, fibrinous deposits, intervillositis, as well as extensive hemorrhagic changes due to SARS-CoV-2 infection probably responsible of IUFD by functional placental insufficiency. In five other cases, we found similar placental lesions but with a focal distribution that did not lead to IUFD but live birth.
These lesions are independent of maternal clinical severity of COVID-19 infection because they occur despite mild maternal symptoms and are therefore difficult to predict. In our cases, they occurred 1–3 weeks after positive SARS-CoV-2 maternal real-time polymerase chain reaction testing and were observed in the 2nd and 3rd trimesters of pregnancies. When these lesions are focal, they do not lead to IUFD and can be involved in intrauterine growth restriction.
Our findings, together with recent observations, suggest that future pregnancy guidance should include stricter pandemic precautions such as screening for a wider array of COVID-19 symptoms, enhanced ultrasound monitoring, as well as newborn medical surveillance.
•Maternal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can generate severe placental lesions.•Some COVID-19–positive unvaccinated mothers show trophoblastic necrosis with positive anti-SARS-CoV-2 immunohistochemitrsy.•SARS-CoV-2 placental lesions can be involved in intrauterine fetal death (10% of cases) when placental damage is massive.•Intrauterine fetal death occurred 1–3 weeks after maternal infection in 2nd and 3rd trimesters of pregnancies.•Severe SARS-CoV-2 placenta lesions occur despite mild maternal COVID-19 symptoms.</description><identifier>ISSN: 0046-8177</identifier><identifier>EISSN: 1532-8392</identifier><identifier>DOI: 10.1016/j.humpath.2021.12.012</identifier><identifier>PMID: 34995674</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Antibodies ; Births ; Coronaviruses ; COVID-19 ; COVID-19 - complications ; COVID-19 placental lesions ; Disease transmission ; Female ; Fetal Death - etiology ; Humans ; Infant, Newborn ; Infections ; Intrauterine fetal death ; Life Sciences ; Miscarriage ; Original Contribution ; Placenta ; Placenta - pathology ; Polymerase chain reaction ; Pregnancy ; Pregnancy Complications, Infectious - pathology ; SARS-CoV-2 ; SARS-Cov-2 infection ; Severe acute respiratory syndrome coronavirus 2</subject><ispartof>Human pathology, 2022-03, Vol.121, p.46-55</ispartof><rights>2022 Elsevier Inc.</rights><rights>Copyright © 2022 Elsevier Inc. All rights reserved.</rights><rights>2022. Elsevier Inc.</rights><rights>Attribution - NonCommercial</rights><rights>2022 Elsevier Inc. All rights reserved. 2022 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c529t-3c8d70b67d1ede984c795968f53c37a6377ca021602a59efc126df44ab056a803</citedby><cites>FETCH-LOGICAL-c529t-3c8d70b67d1ede984c795968f53c37a6377ca021602a59efc126df44ab056a803</cites><orcidid>0000-0003-0420-5081 ; 0000-0003-2371-4113 ; 0000-0002-3745-4044</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.humpath.2021.12.012$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34995674$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://ut3-toulouseinp.hal.science/hal-04555888$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Dubucs, Charlotte</creatorcontrib><creatorcontrib>Groussolles, Marion</creatorcontrib><creatorcontrib>Ousselin, Jessie</creatorcontrib><creatorcontrib>Sartor, Agnès</creatorcontrib><creatorcontrib>Van Acker, Nathalie</creatorcontrib><creatorcontrib>Vayssière, Christophe</creatorcontrib><creatorcontrib>Pasquier, Christophe</creatorcontrib><creatorcontrib>Reyre, Joëlle</creatorcontrib><creatorcontrib>Batlle, Laïa</creatorcontrib><creatorcontrib>Favarel clinical research associate, Stèphanie</creatorcontrib><creatorcontrib>Duchanois midwife, Delphine</creatorcontrib><creatorcontrib>Jauffret clinical research associate, Valèrie</creatorcontrib><creatorcontrib>Courtade-Saïdi, Monique</creatorcontrib><creatorcontrib>Aziza, Jacqueline</creatorcontrib><title>Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death</title><title>Human pathology</title><addtitle>Hum Pathol</addtitle><description>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause severe placental lesions leading rapidly to intrauterine fetal death (IUFD). From August 2020 to September 2021, in the pathology department of Toulouse Oncopole, we analyzed 50 placentas from COVID-19–positive unvaccinated mothers.
The purpose of our study is to describe the clinicopathological characteristics of these placental damages and to understand the pathophysiology.
Ten of them (20%) showed placental lesions with positive immunohistochemistry for SARS-CoV-2 in villous trophoblasts. In five cases (10%), we observed massive placental damage associating trophoblastic necrosis, fibrinous deposits, intervillositis, as well as extensive hemorrhagic changes due to SARS-CoV-2 infection probably responsible of IUFD by functional placental insufficiency. In five other cases, we found similar placental lesions but with a focal distribution that did not lead to IUFD but live birth.
These lesions are independent of maternal clinical severity of COVID-19 infection because they occur despite mild maternal symptoms and are therefore difficult to predict. In our cases, they occurred 1–3 weeks after positive SARS-CoV-2 maternal real-time polymerase chain reaction testing and were observed in the 2nd and 3rd trimesters of pregnancies. When these lesions are focal, they do not lead to IUFD and can be involved in intrauterine growth restriction.
Our findings, together with recent observations, suggest that future pregnancy guidance should include stricter pandemic precautions such as screening for a wider array of COVID-19 symptoms, enhanced ultrasound monitoring, as well as newborn medical surveillance.
•Maternal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can generate severe placental lesions.•Some COVID-19–positive unvaccinated mothers show trophoblastic necrosis with positive anti-SARS-CoV-2 immunohistochemitrsy.•SARS-CoV-2 placental lesions can be involved in intrauterine fetal death (10% of cases) when placental damage is massive.•Intrauterine fetal death occurred 1–3 weeks after maternal infection in 2nd and 3rd trimesters of pregnancies.•Severe SARS-CoV-2 placenta lesions occur despite mild maternal COVID-19 symptoms.</description><subject>Antibodies</subject><subject>Births</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - complications</subject><subject>COVID-19 placental lesions</subject><subject>Disease transmission</subject><subject>Female</subject><subject>Fetal Death - etiology</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Infections</subject><subject>Intrauterine fetal death</subject><subject>Life Sciences</subject><subject>Miscarriage</subject><subject>Original Contribution</subject><subject>Placenta</subject><subject>Placenta - pathology</subject><subject>Polymerase chain reaction</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Infectious - pathology</subject><subject>SARS-CoV-2</subject><subject>SARS-Cov-2 infection</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><issn>0046-8177</issn><issn>1532-8392</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV2LEzEUhoMobnf1JygD3rgXM-Zj8nWjlKKuUBCsehvS5IxNmU5qMlPw35uhddG98Spw8pz3nPe8CL0guCGYiDf7ZjcdjnbcNRRT0hDaYEIfoQXhjNaKafoYLTBuRa2IlFfoOuc9xoTwlj9FV6zVmgvZLpDfwAkSVMfeOhhG21c95BCHXPkJqjFWBztCGkp9s_yyqVfxe02rMHTgxkJVNufoQkH8zIZhTHYqfBig6mBW81BWfIaedLbP8Pzy3qBvH95_Xd3V688fP62W69pxqseaOeUl3grpCXjQqnVScy1Ux5lj0gompbPFrMDUcg2dI1T4rm3tFnNhFWY36O1Z9zhtD-BnQ8n25pjCwaZfJtpg_v0Zws78iCejJMNM8iJwexbYPWi7W67NXMMt51wpdSKFfX0ZluLPCfJoDiE76Hs7QJyyoYIoyrDgbUFfPUD3cZqPOlNMaSGpFoXiZ8qlmHOC7n4Dgs2cudmbS-ZmztwQakrmpe_l367vu_6EXIB3ZwDK7U8BkskuwODAh1RyND6G_4z4DU5Rv-c</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Dubucs, Charlotte</creator><creator>Groussolles, Marion</creator><creator>Ousselin, Jessie</creator><creator>Sartor, Agnès</creator><creator>Van Acker, Nathalie</creator><creator>Vayssière, Christophe</creator><creator>Pasquier, Christophe</creator><creator>Reyre, Joëlle</creator><creator>Batlle, Laïa</creator><creator>Favarel clinical research associate, Stèphanie</creator><creator>Duchanois midwife, Delphine</creator><creator>Jauffret clinical research associate, Valèrie</creator><creator>Courtade-Saïdi, Monique</creator><creator>Aziza, Jacqueline</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><general>WB Saunders</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0420-5081</orcidid><orcidid>https://orcid.org/0000-0003-2371-4113</orcidid><orcidid>https://orcid.org/0000-0002-3745-4044</orcidid></search><sort><creationdate>20220301</creationdate><title>Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death</title><author>Dubucs, Charlotte ; Groussolles, Marion ; Ousselin, Jessie ; Sartor, Agnès ; Van Acker, Nathalie ; Vayssière, Christophe ; Pasquier, Christophe ; Reyre, Joëlle ; Batlle, Laïa ; Favarel clinical research associate, Stèphanie ; Duchanois midwife, Delphine ; Jauffret clinical research associate, Valèrie ; Courtade-Saïdi, Monique ; Aziza, Jacqueline</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-3c8d70b67d1ede984c795968f53c37a6377ca021602a59efc126df44ab056a803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibodies</topic><topic>Births</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - complications</topic><topic>COVID-19 placental lesions</topic><topic>Disease transmission</topic><topic>Female</topic><topic>Fetal Death - etiology</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Infections</topic><topic>Intrauterine fetal death</topic><topic>Life Sciences</topic><topic>Miscarriage</topic><topic>Original Contribution</topic><topic>Placenta</topic><topic>Placenta - pathology</topic><topic>Polymerase chain reaction</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Infectious - pathology</topic><topic>SARS-CoV-2</topic><topic>SARS-Cov-2 infection</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dubucs, Charlotte</creatorcontrib><creatorcontrib>Groussolles, Marion</creatorcontrib><creatorcontrib>Ousselin, Jessie</creatorcontrib><creatorcontrib>Sartor, Agnès</creatorcontrib><creatorcontrib>Van Acker, Nathalie</creatorcontrib><creatorcontrib>Vayssière, Christophe</creatorcontrib><creatorcontrib>Pasquier, Christophe</creatorcontrib><creatorcontrib>Reyre, Joëlle</creatorcontrib><creatorcontrib>Batlle, Laïa</creatorcontrib><creatorcontrib>Favarel clinical research associate, Stèphanie</creatorcontrib><creatorcontrib>Duchanois midwife, Delphine</creatorcontrib><creatorcontrib>Jauffret clinical research associate, Valèrie</creatorcontrib><creatorcontrib>Courtade-Saïdi, Monique</creatorcontrib><creatorcontrib>Aziza, Jacqueline</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Human pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dubucs, Charlotte</au><au>Groussolles, Marion</au><au>Ousselin, Jessie</au><au>Sartor, Agnès</au><au>Van Acker, Nathalie</au><au>Vayssière, Christophe</au><au>Pasquier, Christophe</au><au>Reyre, Joëlle</au><au>Batlle, Laïa</au><au>Favarel clinical research associate, Stèphanie</au><au>Duchanois midwife, Delphine</au><au>Jauffret clinical research associate, Valèrie</au><au>Courtade-Saïdi, Monique</au><au>Aziza, Jacqueline</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death</atitle><jtitle>Human pathology</jtitle><addtitle>Hum Pathol</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>121</volume><spage>46</spage><epage>55</epage><pages>46-55</pages><issn>0046-8177</issn><eissn>1532-8392</eissn><abstract>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause severe placental lesions leading rapidly to intrauterine fetal death (IUFD). From August 2020 to September 2021, in the pathology department of Toulouse Oncopole, we analyzed 50 placentas from COVID-19–positive unvaccinated mothers.
The purpose of our study is to describe the clinicopathological characteristics of these placental damages and to understand the pathophysiology.
Ten of them (20%) showed placental lesions with positive immunohistochemistry for SARS-CoV-2 in villous trophoblasts. In five cases (10%), we observed massive placental damage associating trophoblastic necrosis, fibrinous deposits, intervillositis, as well as extensive hemorrhagic changes due to SARS-CoV-2 infection probably responsible of IUFD by functional placental insufficiency. In five other cases, we found similar placental lesions but with a focal distribution that did not lead to IUFD but live birth.
These lesions are independent of maternal clinical severity of COVID-19 infection because they occur despite mild maternal symptoms and are therefore difficult to predict. In our cases, they occurred 1–3 weeks after positive SARS-CoV-2 maternal real-time polymerase chain reaction testing and were observed in the 2nd and 3rd trimesters of pregnancies. When these lesions are focal, they do not lead to IUFD and can be involved in intrauterine growth restriction.
Our findings, together with recent observations, suggest that future pregnancy guidance should include stricter pandemic precautions such as screening for a wider array of COVID-19 symptoms, enhanced ultrasound monitoring, as well as newborn medical surveillance.
•Maternal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can generate severe placental lesions.•Some COVID-19–positive unvaccinated mothers show trophoblastic necrosis with positive anti-SARS-CoV-2 immunohistochemitrsy.•SARS-CoV-2 placental lesions can be involved in intrauterine fetal death (10% of cases) when placental damage is massive.•Intrauterine fetal death occurred 1–3 weeks after maternal infection in 2nd and 3rd trimesters of pregnancies.•Severe SARS-CoV-2 placenta lesions occur despite mild maternal COVID-19 symptoms.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34995674</pmid><doi>10.1016/j.humpath.2021.12.012</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-0420-5081</orcidid><orcidid>https://orcid.org/0000-0003-2371-4113</orcidid><orcidid>https://orcid.org/0000-0002-3745-4044</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0046-8177 |
ispartof | Human pathology, 2022-03, Vol.121, p.46-55 |
issn | 0046-8177 1532-8392 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8730375 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Antibodies Births Coronaviruses COVID-19 COVID-19 - complications COVID-19 placental lesions Disease transmission Female Fetal Death - etiology Humans Infant, Newborn Infections Intrauterine fetal death Life Sciences Miscarriage Original Contribution Placenta Placenta - pathology Polymerase chain reaction Pregnancy Pregnancy Complications, Infectious - pathology SARS-CoV-2 SARS-Cov-2 infection Severe acute respiratory syndrome coronavirus 2 |
title | Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T12%3A17%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Severe%20placental%20lesions%20due%20to%20maternal%20SARS-CoV-2%20infection%20associated%20to%20intrauterine%20fetal%20death&rft.jtitle=Human%20pathology&rft.au=Dubucs,%20Charlotte&rft.date=2022-03-01&rft.volume=121&rft.spage=46&rft.epage=55&rft.pages=46-55&rft.issn=0046-8177&rft.eissn=1532-8392&rft_id=info:doi/10.1016/j.humpath.2021.12.012&rft_dat=%3Cproquest_pubme%3E2638967296%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2638967296&rft_id=info:pmid/34995674&rft_els_id=S0046817721002203&rfr_iscdi=true |